Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan;80(1):106-131.
doi: 10.1111/all.16429. Epub 2024 Dec 19.

Food Allergy Genetics and Epigenetics: A Review of Genome-Wide Association Studies

Affiliations
Review

Food Allergy Genetics and Epigenetics: A Review of Genome-Wide Association Studies

Aleix Arnau-Soler et al. Allergy. 2025 Jan.

Abstract

In this review, we provide an overview of food allergy genetics and epigenetics aimed at clinicians and researchers. This includes a brief review of the current understanding of genetic and epigenetic mechanisms, inheritance of food allergy, as well as a discussion of advantages and limitations of the different types of studies in genetic research. We specifically focus on the results of genome-wide association studies in food allergy, which have identified 16 genetic variants that reach genome-wide significance, many of which overlap with other allergic diseases, including asthma, atopic dermatitis, and allergic rhinitis. Identified genes for food allergy are mainly involved in epithelial barrier function (e.g., FLG, SERPINB7) and immune function (e.g., HLA, IL4). Epigenome-wide significant findings at 32 loci are also summarized as well as 14 additional loci with significance at a false discovery of < 1 × 10-4. Integration of epigenetic and genetic data is discussed in the context of disease mechanisms, many of which are shared with other allergic diseases. The potential utility of genetic and epigenetic discoveries is deliberated. In the future, genetic and epigenetic markers may offer ways to predict the presence or absence of clinical IgE-mediated food allergy among sensitized individuals, likelihood of development of natural tolerance, and response to immunotherapy.

Keywords: allergy; epigenetics; food allergy; genetics; inheritance.

PubMed Disclaimer

Conflict of interest statement

KN currently reports grants from National Institute of Allergy and Infectious Diseases (NIAID), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Environmental Health Sciences (NIEHS); Stock options from Phylaxis, IgGenix, Seed Health, ClostraBio, Cour; Advisory board for Aravax, Consultant for Excellergy, and Regeneron; Co‐founder of IgGenix; National Scientific Committee member at Immune Tolerance Network (ITN), and National Institutes of Health (NIH) clinical research centers; Scientific advisor for World Health Organization; Patents include, “Mixed allergen com‐position and methods for using the same,” “Granulocyte‐based methods for detecting and monitoring immune system disorders,” and “Methods and Assays for Detecting and Quantifying Pure Subpopulations of White Blood Cells in Immune System Disorders.” PB reports grants from Sanofi, Novartis, and DBV technologies and honoraria from Prizer, Sanofi, Novartis, ALK, DBV technologies, and Astra‐Zeneca. JH has no conflicts of interest to declare. ESC has received research support from DBV Technologies; and has been a member of advisory boards for Pfizer, Miravo, Medexus, Leo Pharma, Kaleo, DBV, AllerGenis, Sanofi, Bausch Health, Avir Pharma, AstraZeneca, ALK, Alladapt. In the past, Dr. Anne K. Ellis has participated in advisory boards for ALK Abello, AstraZeneca, Bausch Health, LEO Pharma, Miravo, Merck, Novartis, has been a speaker for ALK Abello, AstraZeneca, Bausch, Miravo, Medexus, Mylan, Novartis, Pfizer, Sanofi, StallergenesGreer and Regeneron. Her institution has received research grants from ALK Abello, Aralez, AstraZeneca, Bayer LLC, Medexus, Novartis, Sanofi, and Regeneron. She has also served as an independent consultant to Bayer LLC, Pharming, and Regeneron. YA reports grants from the Canadian Dermatology Foundation, the Eczema Society of Canada and unrestricted institutional research support from Sanofi, AbbVie, Pfizer, Novartis, Leo Pharma, performs clinical trials for Leo Pharma and Novartis, and has received speakers' or advisory board honoraria from Pfizer, Sun Pharma, Taro, Sanofi, Eli Lilly, Abbvie, Novartis, Searchlight Pharma, Leo Pharma, UCB, L'Oreal, Boehringer Ingelheim, Kyowa Kirin, Arcutis, Bristol Myers Squibb, Incyte, and Recordati. GHK reports grants from the Netherlands Lung Foundation, ZON‐MW, Ubbo Emmius Foundation, GSK, Vertex, TEVA the Netherlands; all outside the submitted work. His institution has received speakers' honoraria from the exquAIro foundation, Sanofi, Astra‐Zeneca, and Boehringer Ingelheim. MBS is a member of advisory boards for Pfizer, Miravo, Medexus, Sanofi, Novartis, and reports speakers honoraria from Novartis, Sanofi, Medexus, and StallergenesGreer. His institution has received research support from Novartis, Sanofi, and DBV Technologies. TE reports personal fees from Danone/Nutricia/Milupa, grants from DBV, non‐financial support from Novartis, personal fees from ThermoFisher, personal fees from Aimmune, grants and personal fees from ALK, non‐financial support from MADX, personal fees from EFSA, outside the submitted work; he is Co‐I or scientific lead in three investigator initiated oral immunotherapy trials supported by the Food Allergy and Anaphylaxis Program Sickkids and serve as associate editor for Allergy. he recently was and is acting site PI of company sponsored trials by DBV, Novartis and Stallergen. LS, CL, MS, BLT, AMM, MBS, AEC, DV, CH, AJS, BFW, AB, AE, AAS, YS, ET, GK, DD, DM, SE, JG, VS, BDM, and YL report no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Review of genetic and epigenetic mechanisms. Double‐stranded DNA makes up the genome and is coiled to make chromatin fibers and then wrapped around histones to make chromosomes. Genomic changes called single nucleotide polymorphisms (SNP) are a one base‐pair change in germline DNA. These can occur both in exons (protein coding) and introns (non‐coding regions, which often have regulatory function). Changes in DNA that involve a change in repetition of sections of the genome are known as copy number variants (CNV). DNA must be accessible in order to be transcribed into messenger RNAs (mRNA), which constitute the transcriptome. mRNA are then translated into proteins which collectively make up the proteome. Epigenetic mechanisms—shaped by external factors—include DNA methylation, histone modification and non‐coding RNA. Long non‐coding and micro RNAs (miRNA; short single strands of RNA) can bind to transcribed mRNA affecting translation. Genetic and epigenetic modifications can impact protein expression, including a complete lack of protein production, a change in protein levels, or a change in protein sequence that leads to a truncated protein or a protein with impaired function. This figure has been created with BioRender.com.

Similar articles

  • Genetics of Food Allergy.
    Johansson E, Mersha TB. Johansson E, et al. Immunol Allergy Clin North Am. 2021 May;41(2):301-319. doi: 10.1016/j.iac.2021.01.010. Epub 2021 Mar 26. Immunol Allergy Clin North Am. 2021. PMID: 33863485 Free PMC article. Review.
  • Epigenetics and allergy: from basic mechanisms to clinical applications.
    Potaczek DP, Harb H, Michel S, Alhamwe BA, Renz H, Tost J. Potaczek DP, et al. Epigenomics. 2017 Apr;9(4):539-571. doi: 10.2217/epi-2016-0162. Epub 2017 Mar 21. Epigenomics. 2017. PMID: 28322581 Review.
  • Genetics and Epigenetics in Allergic Rhinitis.
    Choi BY, Han M, Kwak JW, Kim TH. Choi BY, et al. Genes (Basel). 2021 Dec 17;12(12):2004. doi: 10.3390/genes12122004. Genes (Basel). 2021. PMID: 34946955 Free PMC article. Review.
  • Epigenomic and epigenetic investigations of food allergy.
    Chun Y, Lee JH, Bunyavanich S. Chun Y, et al. Pediatr Allergy Immunol. 2024 Jan;35(1):e14065. doi: 10.1111/pai.14065. Pediatr Allergy Immunol. 2024. PMID: 38284919 Free PMC article. Review.
  • Genetics of food allergy.
    Hong X, Tsai HJ, Wang X. Hong X, et al. Curr Opin Pediatr. 2009 Dec;21(6):770-6. doi: 10.1097/MOP.0b013e32833252dc. Curr Opin Pediatr. 2009. PMID: 19851108 Free PMC article. Review.

Cited by

References

    1. Warren C. M., Jiang J., and Gupta R. S., “Epidemiology and Burden of Food Allergy,” Current Allergy and Asthma Reports 20, no. 2 (2020): 6. - PMC - PubMed
    1. Koplin J. J., Allen K. J., Gurrin L. C., et al., “The Impact of Family History of Allergy on Risk of Food Allergy: A Population‐Based Study of Infants,” International Journal of Environmental Research and Public Health 10, no. 11 (2013): 5364–5377. - PMC - PubMed
    1. Guarnieri K. M., Saba N. K., Schwartz J. T., et al., “Food Allergy Characteristics Associated With Coexisting Eosinophilic Esophagitis in FARE Registry Participants,” Journal of Allergy and Clinical Immunology in Practice 11, no. 5 (2023): 1509–1521.e1506. - PMC - PubMed
    1. Ullemar V., Magnusson P. K., Lundholm C., et al., “Heritability and Confirmation of Genetic Association Studies for Childhood Asthma in Twins,” Allergy 71, no. 2 (2016): 230–238. - PubMed
    1. Sicherer S. H., Furlong T. J., Maes H. H., Desnick R. J., Sampson H. A., and Gelb B. D., “Genetics of Peanut Allergy: A Twin Study,” Journal of Allergy and Clinical Immunology 106, no. 1 Pt 1 (2000): 53–56. - PubMed

Substances